Health Care [ 5/12 ] | Biotechnology [ 51/74 ]
NASDAQ | Common Stock
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors.
The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors.
It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery.
Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 11, 26 | -0.32 Increased by +65.22% | -0.36 Increased by +11.11% |
| Mar 3, 26 | -0.35 Increased by +56.84% | -0.42 Increased by +14.97% |
| Nov 6, 25 | -0.43 Increased by +54.74% | -0.52 Increased by +17.31% |
| Aug 7, 25 | -0.71 Increased by +22.83% | -0.62 Decreased by -14.52% |
| May 8, 25 | -0.92 Decreased by -17.95% | -0.75 Decreased by -22.67% |
| Feb 25, 25 | -0.82 Decreased by -18.84% | -0.96 Increased by +14.15% |
| Nov 7, 24 | -0.95 Decreased by -35.71% | -0.98 Increased by +3.06% |
| Aug 7, 24 | -0.92 Decreased by -31.43% | -0.85 Decreased by -8.24% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by N/A% | -20.04 M Increased by +64.32% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by -100.00% | -23.58 M Increased by +52.59% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -26.30 M Increased by +54.47% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -43.30 M Increased by +22.48% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -56.17 M Decreased by -19.62% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 2.27 M Decreased by -53.10% | -49.73 M Decreased by -20.98% | Decreased by -2.19 K% Decreased by -157.94% |
| Sep 30, 24 | 0.00 Increased by +100.00% | -57.76 M Decreased by -39.23% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by -100.00% | -55.85 M Decreased by -35.59% | Decreased by N/A% Decreased by N/A% |